Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Przegl Epidemiol ; 78(1): 3-15, 2024 Jun 07.
Artículo en Inglés, Polaco | MEDLINE | ID: mdl-38904307

RESUMEN

Slackia exigua, originally classified as Eubacterium exiguum, is a Gram-positive, asaccharolytic, rod-shaped anaerobic bacterium. The virulence factors of S. exigua have not been accurately identified. The objective of the study is to evaluate the pathogenic potential of S. exigua by presenting the cases of infections diagnosed at our hospital laboratory. Additionally, we reviewed the literature to summarize the experience with S. exigua infections to clarify, in the light of current knowledge, the clinical picture, diagnostic, and therapeutic issues related to this anaerobic bacterium. We reported eleven severe human infections caused by S. exigua. All patients required hospitalization. Nine of the cases involved chronic infections in the stomatognathic system, in two patients, skin infections were diagnosed. As it is known, S. exigua is a component of the human microbiota; however, it can cause opportunistic infections, particularly in the case of translocation outside its natural habitat. A critical literature analysis revealed that S. exigua can be responsible for bacteremia, meningitis, tissue necrosis, periprosthetic joint infection, and osteomyelitis. Several studies have been published regarding the determination of drug susceptibility of S. exigua. The isolated strains were susceptible to most antibiotics used for the treatment of anaerobic infections. The interpretation of antimicrobial susceptibility testing for some slow-growing in vitro, infrequently causing infections anaerobic bacteria, such as S. exigua, is based on The European Committee on Antimicrobial Susceptibility Testing (EUCAST) additional guidance taking into account the determination of drug susceptibility for groups of microorganisms for which cut-off values have not been developed.


Asunto(s)
Antibacterianos , Humanos , Femenino , Masculino , Persona de Mediana Edad , Adulto , Antibacterianos/uso terapéutico , Anciano , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/diagnóstico , Infecciones por Bacterias Grampositivas/microbiología , Polonia
2.
Med Microbiol Immunol ; 210(2-3): 157-163, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33934237

RESUMEN

The aim of the study was to evaluate the pathogenic potential of Bacteroides pyogenes, rarely identified in clinical laboratories anaerobic bacteria. To increase the knowledge about this poorly understood anaerobic microorganism, the study also includes cases of infections described so far in the literature. Only the use of 16S rRNA sequencing and mass spectrometry technique allowed the identification of B. pyogenes from clinical specimens. We reported 13 severe human infections caused by B. pyogenes. Bacteria were cultured from the wound after biting by animals, chronic infections within the oral cavity, from patients with histologically or radiological proven osteomyelitis, surgical site infection, and from urine sample collected after a urological procedure. Most (9/13) of the patients required hospitalization. Almost 70% of them needed urgent admission via the emergency room. Two inpatients due to a life-threatening condition were admitted to the intensive care unit. Almost 50% of isolates were resistant to penicillin. All resistant to penicillin strains were isolated from skin and mucous membrane infections.


Asunto(s)
Infecciones por Bacteroides/microbiología , Bacteroides/clasificación , Bacteroides/patogenicidad , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Bacteroides/efectos de los fármacos , Bacteroides/genética , Infecciones por Bacteroides/diagnóstico , Infecciones por Bacteroides/tratamiento farmacológico , Farmacorresistencia Bacteriana , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , ARN Ribosómico 16S , Estudios Retrospectivos , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Virulencia
3.
Med Sci Monit ; 24: 548-555, 2018 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-29374769

RESUMEN

BACKGROUND Fournier's gangrene (FG) is a fulminant form of infective, polymicrobial, necrotizing fasciitis of the perineal, genital, and perianal regions. It commonly affects men, but women and children may also develop this type of tissue necrosis. MATERIAL AND METHODS This study is a retrospective analysis of the management of 13 cases of Fournier's gangrene, diagnosed from among about 45 000 patients (men, women, and children) treated in the Department of General, Oncological, and Functional Urology (Medical University of Warsaw) from 1995 to 2013. All patients with Fournier's gangrene underwent adequate surgical debridement of the necrotic tissues. Additional procedures (suprapubic cystostomy and orchiectomy) were necessary in 10 out of 13 (77.0%) patients. Seven out of 13 (53.8%) patients required subsequent reconstructive surgery of the scrotum. RESULTS All 13 patients were males, with a median age of 59.6 years (range: 42-68 years). The average hospital stay was 31.9 days (range: 16-46 days). None of our patients died due to Fournier's gangrene. Bacteriological cultures of samples from the wounds showed polymicrobial flora, including the following genera of aerobes and anaerobes: Escherichia, Proteus, Klebsiella, Moraxella, Gemella, Enterococcus, Streptococcus, Staphylococcus, Bacteroides, Pseudoflavonifractor, Parabacteroides, Porphyromonas, Prevotella, Peptoniphilus, Peptostreptococcus, Actinomyces, Collinsella, and Lactobacillus. CONCLUSIONS Favorable outcome of FG treatment with low morbidity and no mortality can be achieved with rapid diagnosis, urgent surgical debridement of all necrotic tissues, and broad-spectrum empirical antimicrobial therapy, usually with combined antibiotics, against aerobic and anaerobic bacteria. Prevention of uroseptic shock by treating localized infection is compulsory.


Asunto(s)
Gangrena de Fournier/patología , Adulto , Anciano , Bacterias Anaerobias/aislamiento & purificación , Gangrena de Fournier/diagnóstico por imagen , Gangrena de Fournier/microbiología , Humanos , Masculino , Persona de Mediana Edad , Escroto/diagnóstico por imagen , Escroto/microbiología , Escroto/patología , Tomografía Computarizada por Rayos X
4.
Pol J Microbiol ; 63(3): 267-73, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25546936

RESUMEN

Fournier's gangrene (FG) is a rapidly progressive form of infective necrotising fasciitis of the perineal, genital, or perianal regions, leading to thrombosis of the small subcutaneous vessels and necrosis of the overlying skin. It is believed that the occurrence of the disease in women is underreported and may be unrecognised by some clinicians. Fournier's gangrene is a life-threatening condition, constituting an urological emergency. Many patients with Fournier's gangrene have medical or surgical conditions, which are predisposing factors to this disease or its more severe or fatal course. These comprise diabetes mellitus, hypertension, alcoholism and advanced age. Recent reports in the literature point to changes in the epidemiology of FG, comprising an increasing age of patients. Several authors reported that the mean age of FG patients is at present 53-55 years. Prognosis in FG patients is based on FGSI (Fournier's gangrene severity index) score. Despite the progress in medical care for FG patients, the mortality rate reported in the literature remains high--most often 20-40%, but ranges from 4% to 80%. The most common isolates cultured from FG lesions are both Gram-positive and Gram-negative, as well as strictly anaerobic bacteria. Recently community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as an etiological agent of FG with severe clinical course and even fulminant sepsis. Rarely FG may have a fungal etiology, being caused by yeast-like fungi Candida spp. or by moulds. Antibiotics should be administered parenterally and in doses high enough to reach an effective concentration in the infected tissues.


Asunto(s)
Antibacterianos/uso terapéutico , Gangrena de Fournier/microbiología , Gangrena de Fournier/tratamiento farmacológico , Gangrena de Fournier/patología , Gangrena de Fournier/cirugía , Humanos , Factores de Riesgo
5.
Transplant Proc ; 56(4): 957-960, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38729836

RESUMEN

BACKGROUND: Pneumonia is a major cause of hospitalization and has a substantial impact on health care costs. Diagnosis and treatment of pneumonia in solid organ transplant (SOT) patients remain a challenge for clinicians in the emergency department. This study aimed to evaluate demographic features, clinical patterns, history of hospitalization, and diagnosis of adult patients after organ(s) transplantation (liver, kidney, pancreas) with severe pneumonia requiring hospitalization. The aim is to determine whether patients undergoing SOT receive or require specific care and whether they need to be prioritized. METHOD: This was a single-center observational study of adult patients after SOT with severe pneumonia requiring hospitalization. The data set for the analysis included only patients with pneumonia as the main reason for hospitalization. The diagnosis of pneumonia was suspected based on the American Thoracic Society criteria. RESULTS: The study revealed that the standard of care for patients with a history of SOT did not significantly differ from care provided to the non-SOT patients with pneumonia admitted to the same hospital during a 94-week period. CONCLUSION: There were notable differences, such as post-transplant patients being transferred more quickly to the hospital ward, having longer hospital stays, and receiving antibiotics earlier than the non-SOT group.


Asunto(s)
Servicio de Urgencia en Hospital , Trasplante de Órganos , Neumonía , Humanos , Neumonía/etiología , Masculino , Persona de Mediana Edad , Femenino , Trasplante de Órganos/efectos adversos , Adulto , Tiempo de Internación , Hospitalización , Antibacterianos/uso terapéutico , Anciano
6.
Pol Przegl Chir ; 95(4): 1-5, 2023 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-36808061

RESUMEN

INTRODUCTION: Correct surgical technique and perioperative care are two factors that can reduce the number of complications, improve treatment outcomes and shorten the length of hospital stay. The introduction of enhanced recovery protocols has changed the approach to patient care in some centers. However, there are significant differences among centers, and in some the standard of care has remained unchanged. AIM: the goal of the panel was to develop recommendations for modern perioperative care in accordance with current medical knowledge in order to reduce the number of complications associated with surgical treatment. An additional goal was to optimize and standardize perioperative care among Polish centers. MATERIALS AND METHODS: the development of these recommendations was based on a review of the available literature from the PubMed, Medline and Cochrane Library databases from January 1, 1985 to March 31, 2022, with particular emphasis on systematic reviews and clinical recommendations of recognized scientific societies. Recommendations were formulated in a directive form and were assessed using the Delphi method. RESULTS AND CONCLUSIONS: 34 recommendations for perioperative care were presented. They cover aspects of pre-, intra- and post-operative care. Implementation of the presented rules allows to improve the results of surgical treatment.


Asunto(s)
Procedimientos Quirúrgicos Electivos , Atención Perioperativa , Humanos , Consenso , Atención Perioperativa/métodos , Complicaciones Posoperatorias , Tiempo de Internación
7.
Pathogens ; 11(7)2022 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-35890024

RESUMEN

This is a single-centre observational study of adult patients with severe pneumonia requiring hospitalization conducted at the emergency department. During the observation period (94 weeks), 398 patients were diagnosed with severe pneumonia and required further treatment at the hospital. The median age of patients was 73 years. About 65% of patients had at least one chronic comorbidity. Almost 30% of patients had cardiovascular disorders, and 13% had diabetes mellitus. The average Emergency Department length of stay was 3.56 days. The average length of hospitalization was 15.8 days. Overall, 94% of patients treated for pneumonia received a beta-lactam antibiotic. The median time from ED admission to the administration of the first dose of antimicrobial agent was less than 6 h. Microbiology test samples were obtained from 48.7% patients. Gram-positive cocci were isolated most commonly (52.9%) from blood samples. Biological material from the lower respiratory tract was collected from 8.3% of patients, and from 47.2% of positive samples, fungi were cultured. The urine samples were obtained from 35.9% patients, and Gram-negative rods (76%) were isolated most commonly. Overall, 16.1% of patients died during the hospitalization. The mean age of patients who died was 79 years. This observational study is the first single-centre study conducted as part of the Polish Emergency Department Research Organization (PEDRO) project. It aims to provide up-to-date information about patients with pneumonia in order to improve medical care and develop local diagnostic and therapeutic recommendations.

8.
Med Sci Monit ; 15(12): CR628-37, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19946234

RESUMEN

BACKGROUND: The study comprises an analysis of bacterial infections in the early period after liver transplantation (LT) in adults. MATERIAL/METHODS: Eighty-three patients were followed for four weeks after LT. Samples comprised mainly blood, urine, surgical-site specimens, sputum, and stool. Culture and identification of the isolated microorganisms was done in accordance with standard microbiological procedures. Susceptibility testing was carried out using CLSI guidelines. Statistical analysis was done with Medi-Stat. RESULTS: In total, 913 samples from LT recipients were cultured. Of the 469 isolated strains, 331 (70.6%) were Gram-positive bacteria, 133 (28.4%) were Gram-negative bacteria, and 5 (1.0%) were yeast-like fungal strains. Of the 284 surgical-site isolates, 222 (78%) were Gram-positive and 61 (21.5%) were Gram-negative bacteria. Of the 99 blood culture isolates, 75 (75.8%) were Gram-positive and 22 (22.2%) of Gram-negative bacterial strains. Of the 73 urine samples, 46 (63.0%) were strains of Gram-negative, 25 (34.0%) of Gram-positive bacteria, and 2 (3.0%) fungal strains. In the 13 respiratory tract samples were 9 (69.0%) Gram-positive and 4 (31.0%) Gram-negative strains. In the 54 stool samples, 63.0% and 16.7% were C. difficile toxin- and culture-positive, respectively. In total, 138 strains of MRCNS, 10 of MRSA, 80 of HLAR, and 19 ESBL(+) were detected. CONCLUSIONS: The isolation of MDR bacterial strains such as MRSA (52.6%), MRCNS (81.7%), HLAR (86.0%), and ESBL(+) Gram-negative rods (12.5%) from patients after LT indicates the need for strict adherence to infection control procedures.


Asunto(s)
Infecciones Bacterianas/etiología , Trasplante de Hígado/efectos adversos , Complicaciones Posoperatorias/etiología , Adolescente , Adulto , Anciano , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/microbiología , Femenino , Hongos/efectos de los fármacos , Hongos/aislamiento & purificación , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/aislamiento & purificación , Bacterias Grampositivas/efectos de los fármacos , Bacterias Grampositivas/aislamiento & purificación , Humanos , Control de Infecciones , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Polonia , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/microbiología , Estudios Prospectivos , Infección de la Herida Quirúrgica/tratamiento farmacológico , Infección de la Herida Quirúrgica/etiología , Infección de la Herida Quirúrgica/microbiología , Factores de Tiempo , Adulto Joven
9.
Med Dosw Mikrobiol ; 61(1): 93-8, 2009.
Artículo en Polaco | MEDLINE | ID: mdl-19517819

RESUMEN

Human herpesvirus 7 (HHV-7) is a beta-herpesvirus widely spread within a population and has been recognized as a potential pathogen in immunocompromised hosts. The goal of the study was development of real-time PCR assay for detection of human herpesvirus 7 DNA in clinical samples, using primers targeting a conserved region of the viral DNA major capside proteine gene and a specific TaqMan hydrolyzing probe. Sixty four plasma samples taken from a group of adult recipients of allogeneic HSCT, during detectable CMV viremia or neutropenic fever, were tested for the presence of viral DNA in the LightCycler system with method described above. HHV-7 DNA was detected in 40 specimens (62.5%). The conclusion is that developed TaqMan-based probes real-time PCR test is very reliable and valuable tool for detection of HHV-7 viremia in plasma samples. The high level of sensitivity and accuracy provided by the LightCycler instrument is favorable for the use of this method in the detection of human herpesvirus 7 DNA in clinical specimens.


Asunto(s)
ADN Viral/aislamiento & purificación , Herpesvirus Humano 7/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Infecciones por Roseolovirus/virología , Viremia/virología , Adulto , Secuencia de Bases , Herpesvirus Humano 7/genética , Humanos
10.
Przegl Epidemiol ; 63(1): 35-8, 2009.
Artículo en Polaco | MEDLINE | ID: mdl-19522223

RESUMEN

Human herpesvirus 6 (HHV-6) has been recognized as a potential significant pathogen in haemopoietic stem cell transplant recipients. Different clinical manifestations have been described including fever, skin rash, bone marrow suppression and encephalitis. The aim of the study was to show frequency of presence of human herpesvirus type 6 DNA in patients of Public Independent Central Clinical Hospital in Warsaw in years 2003-2007. 1357 clinical samples taken from 71 a group of adult recipients of allogeneic HSCT were tested for the presence of HHV-6 DNA using the quantitative in-house real-time PCR assay. Positive results were obtained in 12.5% of all examinations made during described period and also in 35.2% of investigated patients. All of them developed fever of unknown origin, and over 50% had GvHD features. Nine individuals from this group died during detectable HHV-6 viremia.


Asunto(s)
Anticuerpos Antivirales/sangre , ADN Viral/sangre , Herpesvirus Humano 6/aislamiento & purificación , Infecciones por Roseolovirus/diagnóstico , Infecciones por Roseolovirus/epidemiología , Hospitales Públicos/estadística & datos numéricos , Humanos , Polonia/epidemiología , Reacción en Cadena de la Polimerasa , Estudios Retrospectivos , Sensibilidad y Especificidad , Carga Viral
11.
Transplant Proc ; 51(8): 2724-2730, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31477417

RESUMEN

BACKGROUND: One of the most common infective complications after kidney transplant (KTx) is surgical site infection (SSI). Providing indications of improvement of perioperative antibiotic prophylaxis (PAP) and allowing the characterization of risk factors are critical to reduce SSI. The purpose of this study was to evaluate the SSI risk factors and impact of reoperation in the early post-transplant period on SSI occurrence and assess if standard PAP in those cases is a best consideration. METHODS: Between April 2014 and October 2015, a total of 236 KTxs were performed in our center. Deceased donor data, recipient data, and data related to surgical procedures were collected. RESULTS: Surgical site infections were reported in 5.6% (12/214) of patients. Seven patients were diagnosed as having superficial SSI (7/12; 58.3%), 2 with deep SSI (2/12; 16.6%), and 4 with organ-specific SSI (4/12; 33.3%). Extended criteria donor-related transplant, cold ischemia time > 22 hours, dialysis period > 30 months, recipient age older than 45 years, recipient body mass index > 27, induction therapy prior to transplant, diabetes prior to transplant, and ≥ 1 reoperation during 30 days of observation were independent risk factors of SSI occurrence. A total of 19 reoperations were performed in 17 patients. In 8 of all 12 patients with SSI diagnosis, the reoperation was performed (66.7%). In 202 patients of non-SSI patients, only 9 reoperations were performed (4.5%). CONCLUSIONS: Early reoperation after Ktx is a strong risk factor of SSI occurrence. There is a probability that > 4 SSI risk factors and reoperation in the early post-transplant period could require different and more aggressive proceeding, as standard PAP in those cases is insufficient.


Asunto(s)
Trasplante de Riñón , Reoperación/efectos adversos , Infección de la Herida Quirúrgica/epidemiología , Adulto , Anciano , Profilaxis Antibiótica/métodos , Femenino , Humanos , Trasplante de Riñón/efectos adversos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Infección de la Herida Quirúrgica/prevención & control
12.
Transplantation ; 95(6): 878-82, 2013 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-23511213

RESUMEN

BACKGROUND: Kidney transplantation (KTx) is a widely accepted method of renal function replacement therapy. Surgical site infections (SSIs), along with urinary tract infections, are among the most common infective complications after KTx. The purpose of this study was to assess the incidence of SSI in patients after KTx, identify risk factors for SSI, and classify patients in which standard antibiotic prophylaxis could be avoided. METHODS: Between January 2010 and December 2011, 262 KTxs were performed in our center. Deceased donors', recipients' data, and data related to surgical procedures were collected. SSIs were diagnosed in accordance with the guidelines published by the U.S. Centers for Disease Control and Prevention. RESULTS: SSIs were diagnosed in 7.25% (19/262) of patients. Of nineteen SSI patients, two (10.5%) were diagnosed with organ-specific SSIs, which eventually led to graft loss; six (31.5%) developed deep incisional SSIs; and eleven (58%) developed superficial incisional SSIs. Through analysis of this extensive data set, we determined the following risk factors for the development of SSI: kidney from extended criteria donors, a cold ischemia time of more than 30 hr, time of surgical procedure longer than 200 min, confirmed diabetes in the recipients, a recipient body mass index higher than 27 kg/m, and occurrence of delayed graft function. CONCLUSIONS: It may be possible to reduce standard antibiotic prophylaxis to a single dose in patients without known risk factors for SSI. Any opportunity to reduce antibiotic use is crucial in preventing the development of multi-drug-resistant pathogens.


Asunto(s)
Antibacterianos/uso terapéutico , Trasplante de Riñón/efectos adversos , Trasplante de Riñón/métodos , Infección de la Herida Quirúrgica/epidemiología , Adulto , Anciano , Antiinfecciosos/farmacología , Profilaxis Antibiótica/métodos , Índice de Masa Corporal , Femenino , Supervivencia de Injerto , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Infección de la Herida Quirúrgica/prevención & control , Resultado del Tratamiento
13.
Planta Med ; 71(9): 819-24, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16206035

RESUMEN

Six N-benzoylphenylisoserinates of Lactarius sesquiterpenoid alcohols, which previously showed antiviral activities, were tested for their biological properties. Their influence on the mitotic division of the cells and on selected immunological parameters, e. g., T and B lymphocyte proliferation and synthesis of the cytokines: interleukin 2 (IL-2), tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) was assessed in vitro. All of the tested compounds significantly decreased the number of cell divisions. It appears that their influence on cellular divisions may be associated with anti-HSV activity. Moreover, one compound - isolactarorufin 8-epi-[N-benzoyl-(2' R,3' S)-3'-phenylisoserinate] significantly inhibited T lymphocyte proliferation and the synthesis of all tested cytokines.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Agaricales , Proliferación Celular/efectos de los fármacos , Mitosis/efectos de los fármacos , Fitoterapia , Extractos Vegetales/farmacología , Adyuvantes Inmunológicos/administración & dosificación , Adyuvantes Inmunológicos/uso terapéutico , Alcoholes/administración & dosificación , Alcoholes/farmacología , Alcoholes/uso terapéutico , Benzamidas/administración & dosificación , Benzamidas/farmacología , Benzamidas/uso terapéutico , Humanos , Leucocitos Mononucleares/citología , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Serina/administración & dosificación , Serina/análogos & derivados , Serina/farmacología , Serina/uso terapéutico , Sesquiterpenos/administración & dosificación , Sesquiterpenos/farmacología , Sesquiterpenos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA